Efficacy of nasopancreatic stenting prior to laparoscopic enucleation of pancreatic neuroendocrine tumor

2013 ◽  
Vol 6 (2) ◽  
pp. 140-142 ◽  
Author(s):  
Takeyuki Misawa ◽  
Hiroo Imazu ◽  
Yuki Fujiwara ◽  
Hiroaki Kitamura ◽  
Nobuhiro Tsutsui ◽  
...  
Keyword(s):  
Neuroendocrine Tumor ◽  
Pancreatic Neuroendocrine Tumor ◽  
Laparoscopic Enucleation

scholarly journals Laparoscopic enucleation of a neuroendocrine tumor at the back wall of the pancreas - case report and literature review

2020 ◽  
pp. 115-115
Author(s):  
Dragan Eric ◽  
Vladimir Milosavljevic ◽  
Boris Tadic ◽  
Dragan Gunjic ◽  
Milos Bjelovic
Keyword(s):  
Neuroendocrine Tumor ◽  
Histopathological Examination ◽  
Incidental Finding ◽  
Pancreatic Neuroendocrine Tumor ◽  
Dorsal Side ◽  
The Body ◽  
Diagnostic Challenge ◽  
Back Wall ◽  
Efficient Manner ◽  
Laparoscopic Enucleation

Introduction Introduction. Neuroendocrine tumors of the pancreas are rare neoplasms. They are divided into two groups: functional and non-functional. Non-functional tumors represent a diagnostic challenge, given that they often remain asymptomatic and are diagnosed as an incidental finding. Case outline. We present a patient in whom the tumor was discovered at the junction of the body and the tail of the pancreas on the dorsal side. The patient had no specific symptomatology, with no loss in body weight. Considering the conducted diagnostics and the condition of the patient, we decided to perform a laparoscopic enucleation. This procedure has been applied in a safe and efficient manner, so the operative and postoperative course passed without complications. The definitive histopathological examination confirmed the finding that it was a non-functional pancreatic neuroendocrine tumor. Conclusion. Laparoscopic enucleation is an effective and safe treatment modality of these tumors with well-known advantages compared to open surgery, but there is always a tending to improve already existing results and thus to contribute not only to treatment but to greater and better comfort of the patient

Case report: Refractory hypercalcemia due to a pancreatic neuroendocrine tumor misdiagnosed as adenocarcinoma

2020 ◽  
Author(s):  
Mirella Hage ◽  
Ségolène Hescot ◽  
Amani Asnacios ◽  
Sophia Bakopoulou ◽  
Laure Cazabat ◽  
...  
Keyword(s):  
Case Report ◽  
Neuroendocrine Tumor ◽  
Pancreatic Neuroendocrine Tumor

scholarly journals Heterogeneity of the Clinical Presentation of the MEN1 LRG_509 c.781C>T (p.Leu261Phe) Variant Within a Three-Generation Family

Genes ◽  
2021 ◽  
Vol 12 (4) ◽  
pp. 512
Author(s):  
Aleksandra Gilis-Januszewska ◽  
Anna Bogusławska ◽  
Kornelia Hasse-Lazar ◽  
Beata Jurecka-Lubieniecka ◽  
Barbara Jarząb ◽  
...  
Keyword(s):  
Neuroendocrine Tumor ◽  
Clinical Presentation ◽  
Age Of Onset ◽  
Malignant Tumors ◽  
Genetic Disorder ◽  
Family Members ◽  
Pancreatic Neuroendocrine Tumor ◽  
Index Patient ◽  
Generation Family

Multiple neuroendocrine neoplasia type 1 (MEN1) is a rare genetic disorder with an autosomal dominant inheritance, predisposing carriers to benign and malignant tumors. The phenotype of MEN1 syndrome varies between patients in terms of tumor localization, age of onset, and clinical aggressiveness, even between affected members within the same family. We describe a heterogenic phenotype of the MEN1 variant c.781C>T (LRG_509t1), which was previously reported only once in a family with isolated hyperparathyroidism. A heterozygous missense variant in exon 4 of the gene was identified in the sequence of the MEN1 gene, i.e., c.781C>T, leading to the amino acid change p.Leu261Phe in a three-generation family. In the screened family, 5/6 affected members had already developed hyperparathyroidism. In the index patient and two other family members, an aggressive course of pancreatic neuroendocrine tumor (insulinoma and non-functioning neuroendocrine tumors) with dissemination was diagnosed. In the index patient, late diagnosis and slow progression of the disseminated neuroendocrine tumor have been observed (24 years of follow-up). The very rare variant of MEN1, LRG_509t1 c.781C>T /p.Leu261Phe (LRG_509p1), diagnosed within a three-generation family has a heterogenic clinical presentation. Further follow-up of the family members should be carried out to confirm the spectrum and exact time of clinical presentation.

Management of the primary tumor in patients with metastatic pancreatic neuroendocrine tumor: a contemporary single-institution review

2009 ◽  
Vol 197 (3) ◽  
pp. 376-381 ◽  
Author(s):  
Matias Bruzoni ◽  
Purvi Parikh ◽  
Rolando Celis ◽  
Chandrakanth Are ◽  
Quan P. Ly ◽  
...  
Keyword(s):  
Neuroendocrine Tumor ◽  
Primary Tumor ◽  
Pancreatic Neuroendocrine Tumor ◽  
Single Institution

Novel recurrence risk stratification of resected pancreatic neuroendocrine tumor

2018 ◽  
Vol 412 ◽  
pp. 188-193 ◽  
Author(s):  
Heli Gao ◽  
Liang Liu ◽  
Wenquan Wang ◽  
Huaxiang Xu ◽  
Kaizhou Jin ◽  
...  
Keyword(s):  
Risk Stratification ◽  
Neuroendocrine Tumor ◽  
Pancreatic Neuroendocrine Tumor ◽  
Recurrence Risk
Sign in / Sign up

Export Citation Format

Share Document